EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Exon-Based Transcriptomic Analysis of Parkinson’s Disease

Sulev Kõks iD

Biomolecules · 2025

DOI: 10.3390/biom15030440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Sulev Kõks. Beteiligte Einrichtung: Personalised Medicine Centre, Health Futures Institute, Murdoch University, Perth, WA 6150, Australia. Hauptthemen laut MEDLINE: Parkinson Disease, Exons, Gene Expression Profiling, Transcriptome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael J Fox Foundation, MSWA, The Michael J. Fox Foundation, Shake It Up Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a neurodegenerative disease with a complicated pathophysiology and diagnostics. Blood-based whole transcriptome analysis of the longitudinal PPMI cohort was performed with a focus on the change in the expression of exons to find potential RNA-based biomarkers. At the moment of diagnosis, the expression of exons was very similar in both control and PD patients. The exon-based analysis identified 27 differentially expressed exons in PD patients three years after the diagnosis compared to the health controls. Moreover, thirteen exons were differentially expressed during the three-year progression of the PD. At the same time, control subjects had only minimal changes that can mostly be attributed to being related to aging. Differentially regulated exons we identified in the PD cohort were mostly related to different aspects of the pathophysiology of PD, such as an innate immune response or lysosomal activity. We also observed a decline in the expression of the OPN1MW3 gene that is related to colour vision, which suggests that colour vision analysis could be a practical biomarker to monitor the progression of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseExonsGene Expression ProfilingTranscriptomeHumansMaleFemaleAgedMiddle AgedBiomarkers

Stichwörter der Autor:innen

PPMIParkinson’s diseaseRNA-seqblood transcriptomeexonstranscriptomewhole transcriptome analysis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Personalised Medicine Centre, Health Futures Institute, Murdoch University, Perth, WA 6150, Australia.
  • Perron Institute for Neurological and Translational Science, Perth, WA 6009, Australia.

ORCID-Profile: Sulev Kõks

Förderung

  • Michael J Fox Foundation
  • MSWA, The Michael J. Fox Foundation
  • Shake It Up Australia
  • The Perron Institute

Zitieren

APA

Kõks, S. (2025). The Exon-Based Transcriptomic Analysis of Parkinson’s Disease. Biomolecules. https://doi.org/10.3390/biom15030440

Vancouver

Kõks S. The Exon-Based Transcriptomic Analysis of Parkinson’s Disease. Biomolecules. 2025. doi:10.3390/biom15030440

BibTeX
@article{Kks2025,
  author = {Kõks, Sulev},
  title = {The Exon-Based Transcriptomic Analysis of Parkinson’s Disease},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15030440}
}
Kostenlos starten →